China Pharma Holdings
CPHI
6 hedge funds and large institutions have $88.3K invested in China Pharma Holdings in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
118% more capital invested
Capital invested by funds: $40.4K → $88.3K (+$47.8K)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
20% more funds holding
Funds holding: 5 → 6 (+1)
0.09% more ownership
Funds ownership: 0.09% → 0.18% (+0.09%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$16.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$12.1K |
| 3 |
Renaissance Technologies
New York
|
+$10.5K |
| 4 |
HF
HRT Financial
New York
|
+$5.74K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$3.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$10.2K |
| 2 |
Citigroup
New York
|
-$1.24K |
| 3 |
FCT
First Community Trust
Dubuque,
Iowa
|
-$7 |
CPHI Hedge Fund Activity: Q1 2025 in Review
6 of the 7,466 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q1 2025, worth a combined $88.3K — up 118% from $40.4K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CPHI positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $16.7K. The largest seller was Two Sigma Securities, cutting an estimated $10.2K.
- 6 institutional investors held China Pharma Holdings (CPHI) as of Q1 2025, up from 5 in Q4 2024.
- Funds reported $88.3K of China Pharma Holdings stock for Q1 2025, up 118% quarter-over-quarter.
- 3 funds opened new China Pharma Holdings positions in Q1 2025 and 2 closed out, a net change of +1 holder.
- The largest China Pharma Holdings buyer in Q1 2025 was UBS Group, an estimated $16.7K added.
- The largest China Pharma Holdings seller in Q1 2025 was Two Sigma Securities, an estimated $10.2K sold.
Based on aggregated 13F filings for Q1 2025.